MedPath

The Use of Stromal Vascular Fraction for Knee Arthrosis

Not Applicable
Recruiting
Conditions
Knee Arthrosis
Registration Number
NCT06171204
Lead Sponsor
University Hospital, Ghent
Brief Summary

A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis.

Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.

Detailed Description

Stromal Vascular Fraction (SVF) from adipose tissue is increasingly being used in the clinic for a variety of conditions (skin disorders, joint pain, etc.). SVF is a collective term for cells that can be obtained from liposuction fat. These cells can be separated from the fat by mechanical processing of the liposuction fat combined with an additional centrifugation.

Despite the fact that enough SVF can be isolated after such a liposuction for multiple treatments (\>3), our research group has found a way to safely freeze SVF without significant loss of SVF cells. In this way, a patient would only have to undergo one liposuction and associated anesthesia to be able to obtain multiple SVF treatments.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Legal capacity
  • Osteochondral lesions
  • Inflammatory complaints
  • (Peri)tendinitis or tendinopathies and ligamentous injuries
  • Impingement complaints
  • Arthrofibrosis
  • Anterior knee pain
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evaluation of the safety of SVF injections after cryo preservation1 year

The patient will complete the KOOS questionnaire (Knee Injury and Osteoarthritis Outcome Score) on several timepoints.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UZ GENT

🇧🇪

Gent, Oost-Vlaanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath